68 related articles for article (PubMed ID: 24805199)
1. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
[TBL] [Abstract][Full Text] [Related]
2. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
3. In(OTf)
Chang MY; Lai KX; Chang YL
RSC Adv; 2020 May; 10(31):18231-18244. PubMed ID: 35517185
[TBL] [Abstract][Full Text] [Related]
4. Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
Jordan VC
Breast Cancer Res Treat; 2021 Nov; 190(1):19-38. PubMed ID: 34398352
[TBL] [Abstract][Full Text] [Related]
5. The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells.
Maximov PY; Abderrahman B; Hawsawi YM; Chen Y; Foulds CE; Jain A; Malovannaya A; Fan P; Curpan RF; Han R; Fanning SW; Broom BM; Quintana Rincon DM; Greenland JA; Greene GL; Jordan VC
Mol Pharmacol; 2020 Jul; 98(1):24-37. PubMed ID: 32362585
[TBL] [Abstract][Full Text] [Related]
6. Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer.
Maximov PY; Abderrahman B; Fanning SW; Sengupta S; Fan P; Curpan RF; Rincon DMQ; Greenland JA; Rajan SS; Greene GL; Jordan VC
Mol Pharmacol; 2018 Aug; 94(2):812-822. PubMed ID: 29739819
[TBL] [Abstract][Full Text] [Related]
7. Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.
Klopp-Schulze L; Joerger M; Wicha SG; Ter Heine R; Csajka C; Parra-Guillen ZP; Kloft C
Clin Pharmacokinet; 2018 Feb; 57(2):229-242. PubMed ID: 28540639
[TBL] [Abstract][Full Text] [Related]
8. The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.
Fan P; Maximov PY; Curpan RF; Abderrahman B; Jordan VC
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):245-63. PubMed ID: 26052034
[TBL] [Abstract][Full Text] [Related]
9. The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.
Jordan VC
Endocr Relat Cancer; 2015 Feb; 22(1):R1-31. PubMed ID: 25339261
[TBL] [Abstract][Full Text] [Related]
10. Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.
Maximov PY; McDaniel RE; Fernandes DJ; Korostyshevskiy VR; Bhatta P; Mürdter TE; Flockhart DA; Jordan VC
Br J Pharmacol; 2014 Dec; 171(24):5624-35. PubMed ID: 25073551
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
13. From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells.
Brooks SC; Skafar DF
Steroids; 2004 Jun; 69(6):401-18. PubMed ID: 15219790
[TBL] [Abstract][Full Text] [Related]
14. Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.
Maximov PY; Fernandes DJ; McDaniel RE; Myers CB; Curpan RF; Jordan VC
J Med Chem; 2014 Jun; 57(11):4569-83. PubMed ID: 24805199
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.
Maximov PY; McDaniel RE; Fernandes DJ; Bhatta P; Korostyshevskiy VR; Curpan RF; Jordan VC
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25258390
[TBL] [Abstract][Full Text] [Related]
16. A convenient synthesis of (Z)-4-hydroxy-N-desmethyltamoxifen (endoxifen).
Fauq AH; Maharvi GM; Sinha D
Bioorg Med Chem Lett; 2010 May; 20(10):3036-8. PubMed ID: 20400308
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]